TI
FOLD

Turner Investments’s Amicus Therapeutics FOLD Stock Holding History

Turner Investments’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-90,000
Closed -$1.26M – 241
2015
Q3 		$1.26M Buy
90,000
+11,310
+14% +$177K 0.25% 119
2015
Q2 		$1.11M Buy
+78,690
New +$946K 0.2% 156
2014
Q2 		– Sell
-252,774
Closed -$523K – 587
2014
Q1 		$523K Buy
+252,774
New +$632K 0.01% 482

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Turner Investments's FOLD Position: Q4 2015 in Review

Turner Investments sold out of Amicus Therapeutics (FOLD) in Q4 2015, closing a stake of 90,000 shares — an estimated $1.26M sold.

Turner Investments first reported a position in FOLD in Q1 2014 and held it in 3 quarters. The position peaked at $1.26M in Q3 2015. 139 funds tracked by Wall St. Rank hold FOLD as of Q4 2015.

  • Turner Investments reported no remaining Amicus Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Turner Investments sold 90,000 Amicus Therapeutics shares in Q4 2015, an estimated $1.26M.
  • Turner Investments first reported a position in Amicus Therapeutics in Q1 2014 and held it in 3 quarters.
  • Turner Investments's Amicus Therapeutics position peaked at $1.26M in Q3 2015.
  • 139 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2015.

Based on Turner Investments's 13F filing for Q4 2015, filed 9 Feb 2016.